Skip to main content
Caplight Logo









U.S. Army Medical Research Acquisition Activity

U.S. Army Medical Research Acquisition Activity

Marylandhealth.mil

Overview

U.S. Army Medical Research Acquisition Activity is a United States government entity that serves as the contracting and assistance agreement arm of the U.S. Army Medical Research and Development Command, providing funding for medical research and development through contracts and grants.

Year Founded

1984

Portfolio Companies

9

Website

health.mil

Investments

U.S. Army Medical Research Acquisition Activity investments
CompanyDateStageLead
HDT Bio Corp.Aug 2022GrantCo-investor
Synedgen, Inc.Dec 2019GrantLead
Sanaria Inc.May 2005GrantCo-investor
Cellphire TherapeuticsJan 2020GrantCo-investor
PuraCath MedicalSep 2016GrantCo-investor
Book a demo to see all 9 portfolio companies

For institutional investors. Book with your work email.

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Portfolio analytics

Caplight clients see full sector, stage and valuation breakdowns for this investor.

Book a demo to see full analytics

For institutional investors. Book with your work email.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Portfolio analytics

Caplight clients see yearly investment pace and funding raised over time.

Book a demo to see full analytics

For institutional investors. Book with your work email.

FAQ

Where is U.S. Army Medical Research Acquisition Activity based?

U.S. Army Medical Research Acquisition Activity is headquartered in Maryland, United States.

When was U.S. Army Medical Research Acquisition Activity founded?

U.S. Army Medical Research Acquisition Activity was founded in 1984.

How many portfolio companies does U.S. Army Medical Research Acquisition Activity have?

U.S. Army Medical Research Acquisition Activity has 9 portfolio companies in Caplight's dataset.

What are some companies in U.S. Army Medical Research Acquisition Activity's portfolio?

Portfolio companies visible on Caplight include HDT Bio Corp., Synedgen, Inc., Sanaria Inc., Cellphire Therapeutics, PuraCath Medical.

What was U.S. Army Medical Research Acquisition Activity's most recent investment shown here?

U.S. Army Medical Research Acquisition Activity's most recent investment in this portfolio sample was in HDT Bio Corp. in 2022.

What sectors does U.S. Army Medical Research Acquisition Activity focus on?

U.S. Army Medical Research Acquisition Activity focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Energy & Sustainability, Frontier & Industrial Tech, Frontier & Industrial Tech, Frontier & Industrial Tech.

What company stages does U.S. Army Medical Research Acquisition Activity focus on?

Stage focus information for U.S. Army Medical Research Acquisition Activity is not publicly available.

Firmographic Details

HeadquartersMaryland
Year Founded1984

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?